ABIVAX Société Anonyme (EPA: ABVX)
11.44
0.00 (0.00%)
Aug 30, 2024, 5:35 PM CET
ABIVAX Société Anonyme Revenue
ABIVAX Société Anonyme had revenue of 271.53M EUR in the half year ending June 30, 2024, a decrease of -5.57%. This brings the company's revenue in the last twelve months to 528.82M, down -10.37% year-over-year. In the year 2023, ABIVAX Société Anonyme had annual revenue of 580.95M with 4.89% growth.
Revenue (ttm)
528.82M
Revenue Growth
-10.37%
P/S Ratio
109.65
Revenue / Employee
73.66K
Employees
61
Market Cap
723.76M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 580.95M | 27.09M | 4.89% |
Dec 31, 2022 | 553.86M | 67.36M | 13.85% |
Dec 31, 2021 | 486.50M | 91.00M | 23.01% |
Dec 31, 2020 | 395.50M | 26.66M | 7.23% |
Dec 31, 2019 | 368.84M | 57.65M | 18.52% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
LVMH Moët Hennessy - Louis Vuitton, Société Européenne | 85.59B |
Hermès International Société en commandite par actions | 14.23B |
L'Oréal S.A. | 42.73B |
Schneider Electric S.E. | 36.44B |
Christian Dior SE | 85.59B |
EssilorLuxottica Société anonyme | 25.83B |
L'Air Liquide S.A. | 27.01B |
ABIVAX Société Anonyme News
- 26 days ago - Abivax Announces ABTECT Phase 3 Trial Achieves Key Enrollment Milestone - GlobeNewsWire
- 6 weeks ago - Abivax Provides Operational and Key Program Update - GlobeNewsWire
- 3 months ago - Abivax releases the results of its May 30, 2024 Ordinary and Extraordinary General Meeting - GlobeNewsWire
- 5 months ago - Abivax reports 2023 financial results and operational update - GlobeNewsWire
- 7 months ago - Abivax Announces Presentation of Four Abstracts for Obefazimod in Ulcerative Colitis and Sponsorship of Scientific Symposium at The 19th Congress of European Crohn's and Colitis Organization (ECCO) - Accesswire
- 11 months ago - Citi Appointed as Depositary Bank for Abivax SA's ADR Program - Business Wire
- 11 months ago - Abivax Announces Closing of its Initial Public Offering on the Nasdaq Global Market - Accesswire
- 11 months ago - Abivax Announces Trading Resumption of its Ordinary Shares on Euronext Paris - Accesswire